We demonstrated for the first time that 9,10-dimethyl-l,2-benzanthracene (DMBA)-treated hamsters showed hypertriglyceridemia followed by cachexia. Hypertriglyceridemia is believed to be caused in part by the decreased lipoprotein lipase (LPL) activity, and by cytokines such as tumor necrosis factor (TNF)-a. In addition, TNF-a action is associated with the LPL activity. Therefore, we determined the content of triglyceride (TG), LPL, and TNF-a in the serum from DMBA-treated hamsters. Elevated TG concentration in the serum of tumor-bearing hamsters was more remarkable and preceded the increase in other lipids, whereas the activity of LPL, the key enzyme of TG metabolism in vivo, was drastically reduced. TNF-a, known as an endogenous inhibitor of LPL activity, was detected in both the sera and the extract of tumors from DMBA-treated hamsters, whereas it was not detectable in any control samples. Pre-incubation of control sera with exogenous recombinant human TNF-a resulted in a potent inhibition of endogenous LPL activity in a dose-dependent manner in vitro. Therefore, the presence of TNF-a might lead to the increase in plasma TG mediated by LPL in tumor-bearing hamsters.
Allain CC, Poon LS, Chan CS, Richmond W., Fu PC (1974). Enzymatic determination of total serum cholesterol . Clin Chem20:470-475.
2.
Barclay M., Skipski VP (1975). Lipoproteins in relation to cancer. Prog Biochem Pharmacol10:76-111.
3.
Beutler B., Cerami A. (1986). Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature320:584-588.
4.
Bradford MM (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem72:248-254.
5.
Chisari FV (1977). Immunoregulatory properties of human plasma in very low density lipoproteins. J Immunol119:2129-2136.
6.
Enerback S., Semb H., Tavernier J., Bjursell G., Olivecrona T. (1988). Tissue-specific regulation of guinea pig lipoprotein lipase; effects of nutritional state and of tumor necrosis factor on mRNA levels in adipose tissue, heart and liver. Gene64:97-106.
7.
Fearon KC, Carter DC (1988). Cancer cachexia. Ann Surg208:1-5.
8.
Feingold KR, Grunfeld C. (1987). Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest80:184-190.
9.
Fiser RH, Denniston JC, Beisel WR (1972). Infection with Diplococcus pneumoniae and Salmonella typhimurium in monkeys: changes in plasma lipids and lipoproteins. J Infect Dis125:54-60.
10.
Grunfeld C., Palladino MA Jr. (1990). Tumor necrosis factor: Immunologic, antitumor, metabolic and cardiovascular activities. Adv Intern Med35:45-71.
11.
Grunfeld C., Gulli R., Moser AH, Gavin LA, Feingold KR (1989). Effect of tumor necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res30:579-585.
12.
Holmes S., Dickerson JW (1987). Malignant disease: nutritional implications of disease and treatment. Cancer Metastasis Rev6:357-381.
13.
Kannan R., Baker N. (1977). Hypertriglyceridemia in Ehrlich ascites carcinomatous mice: tumor and mouse strain differences. Lipids12:153-158.
14.
Kage T., Mogi M., Katsumata Y., Chino T. (1987). Regional lymph node metastasis created by partial excision of carcinomas induced in hamster cheek pouch with 9,10-dimethyl-1,2-benzanthracene . J Dent Res66:1673-1679.
15.
Kage T., Mogi M., Katsumata Y., Yamada T., Chino T. (1988). Lung and cervical lymph-node metastasis after cortisone enhancement in hamster cheek-pouch carcinogenesis. Arch Oral Biol33:459-461.
16.
Kaufmann RL, Matson CF, Beisel WR (1976). Hypertriglyceridemia produced by endotoxin: role of impaired triglyceride disposal mechanisms. J Infect Dis133:548-555.
17.
Kawakami M., Cerami A. (1981). Studies of endotoxin-induced decrease in lipoprotein lipase activity. J Exp Med154:631-639.
18.
Kawakami M., Pekala PH, Lane MD, Cerami A. (1982). Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci USA79:912-916.
19.
Kobayashi K., Ogasawara N., Sakaguchi T., Taniuchi K., Matsuoka A. (1989). Serum glycated beta-lipoprotein determined by agarose-gel electrophoresis with nitroblue tetrazolium coloration. Clin Chem35:177-178.
20.
Kushiro H., Takano Y., Fukui I. (1975). Determination of lipoprotein lipase activity. Jpn J Clin Pathol21:110-123.
21.
Laurell S., Tibbling G. (1967). Colorimetric micro-determination of free fatty acids in plasma. Clin Chim Acta16:57-62.
22.
Mogi M., Kojima K., Nagatsu T. (1984). Detection of inactive or less active forms of tyrosine hydroxylase in human adrenals by a sandwich enzyme immunoassay. Anal Biochem138:125-132.
23.
Mogi M., Hiraoka BY, Harada M., Kage T., Chino T. (1986). Analysis and identification of human parotid salivary proteins by micro two-dimensional electrophoresis and Western blot techniques . Arch Oral Biol31:337-339.
24.
Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T. (1994). Tumor necrosis factor-a increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci Lett165:208-210.
25.
Morse JH, Witte LD, Goodman DS (1977). Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. J Exp Med146:1791-1803.
26.
Nagele U., Hagele EO, Sauer G., Wiedemann E., Lehmann P., Wahlefold AW, et al. (1984). Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem22:165-174.
27.
Rouzer CA, Cerami A. (1980). Hypertriglyceridemia associated with trypanosoma Brucei infection in rabbits: role of defective triglyceride removal. Molec Biochem Parasitol2:31-38.
28.
Salley JJ (1954). Experimental carcinogenesis in the cheek pouch of the Syrian hamster. J Dent Res33:253-262.
29.
Schwartz J., Suda D., Light G. (1986). Beta carotene is associated with the regression of hamster buccal pouch carcinoma and the induction of tumor necrosis factor in macrophages. Biochem Biophys Res Commun136:1130-1135.
30.
Semb H., Peterson J., Tavernier J., Olivecrona T. (1987). Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem262:8390-8394.
31.
Shklar G., Schwartz J. (1988). Tumor necrosis factor in experimental cancer regression with alphatocophenol, beta-carotene, canthaxanthin and algae extract. Eur J Cancer Clin Oncol24:839-850.
32.
Takayama M., Itoh S., Nagasaki T., Tanimizu I. (1977). A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta79:93-98.
33.
Thoen CO, Karlson AG, Ellefson RD (1972). Mechanism of changes in serum lipid lipoprotein profiles in the infectious disease. Mayo Clin Proc47:270-272.
34.
Tracey KJ, Cerami A. (1994). Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Ann Rev Med45:491-503.
35.
Tracey KJ, Cerami A. (1992). Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med200:233-239.
36.
Vannier C., Deslex S., Pradines-Figueres A., Ailhaud G. (1989). Biosynthesis of lipoprotein lipase in cultured mouse adipocytes. J Biol Chem264:13199-13205.
37.
Yamada T., Kage T., Wakano T., Nakajima J., Mogi M., Chino T. (1988). Serum sialic acid alterations in the hamster cheek pouch carcinogenesis. Jpn J Oral Biol30:695-698.
38.
Yamada T., Mogi M., Kage T., Ueda A., Nakajima J., Chino T. (1992). Enhancement by cyclosporin A of metastasis from hamster cheek pouch carcinoma. Arch Oral Biol37:593-596.
39.
Yui S., Yamazaki M. (1986). Induction of macrophage growth by lipids. J Immunol136:1334-1338.
